withdraws
0
![FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants](https://s3.amazonaws.com/syndication.abcaudio.com/files/2023-01-27/GettyImages_FDA_012723.jpg)
Sarah Silbiger/Getty Images (WASHINGTON) — The U.S. Food and Drug Administration said Thursday it is withdrawing its emergency use authorization of a COVID-19 antibody therapy as a prevention tool because it is unlikely to be effective against variants that are currently circulating. Evusheld, which is made by British-Swedish pharmaceutical and biotechnology company, AstraZeneca, was first […]
-
Pages